Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Related Filers (13)
- Verve Therapeutics, Inc. (4)
- Aligos Therapeutics, Inc. (4)
- Black Diamond Therapeutics, Inc. (2)
- Generation Bio Co. (2)
- Forma Therapeutics Holdings, Inc., (2)
- Nurix Therapeutics, Inc. (2)
- Kymera Therapeutics, Inc. (2)
- Dyne Therapeutics, Inc. (2)
- PMV Pharmaceuticals, Inc. (2)
- Olema Pharmaceuticals, Inc. (2)
- Edgewise Therapeutics, Inc. (2)
- Nuvalent, Inc. (2)
- Acrivon Therapeutics, Inc. (2)
- Show More ...
Other (2)
D/A
Thursday, 9/3/2020
Exempt (Private) Offering
D
Thursday, 10/3/2019
Exempt (Private) Offering
Ownership (30)
4
Monday, 11/21/2022
Acrivon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/9/2022
Acrivon Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Friday, 2/4/2022
Verve Therapeutics, Inc.: Major Shareholders
SC 13G/A
Friday, 2/4/2022
Aligos Therapeutics, Inc.: Major Shareholders
4
Tuesday, 8/3/2021
Nuvalent, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/28/2021
Nuvalent, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Monday, 6/28/2021
Verve Therapeutics, Inc.: Major Shareholders
4
Tuesday, 6/22/2021
Verve Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/16/2021
Verve Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 3/30/2021
Edgewise Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/25/2021
Edgewise Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 11/24/2020
Olema Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/18/2020
Olema Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Thursday, 10/22/2020
Aligos Therapeutics, Inc.: Major Shareholders
4
Thursday, 10/22/2020
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/15/2020
Aligos Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 9/29/2020
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/24/2020
PMV Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 9/23/2020
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/16/2020
Dyne Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 8/27/2020
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 8/20/2020
Kymera Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 7/30/2020
Nurix Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/23/2020
Nurix Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/25/2020
Forma Therapeutics Holdings, Inc.,: Statement of changes in beneficial ownership of securities
3
Thursday, 6/18/2020
Forma Therapeutics Holdings, Inc.,: Initial statement of beneficial ownership of securities
4
Thursday, 6/18/2020
Generation Bio Co.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/11/2020
Generation Bio Co.: Initial statement of beneficial ownership of securities
4
Wednesday, 2/5/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/29/2020
Black Diamond Therapeutics, Inc.: Initial statement of beneficial ownership of securities